|
Forecast Period
|
2026-2030
|
|
Market Size (2024)
|
USD 91.35 Billion
|
|
Market Size (2030)
|
USD 125.28 Billion
|
|
CAGR (2025-2030)
|
5.38%
|
|
Fastest Growing Segment
|
Intravenous Antibiotics Treatment
|
|
Largest Market
|
North America
|
Market Overview
Global Vascular Access Procedures
Market was valued at USD 91.35 Billion in 2024 and is expected to reach USD 125.28
Billion by 2030 with a CAGR of 5.38%. The Global Vascular Access Procedures Market is
witnessing substantial expansion as a result of increasing healthcare demands
and the growing burden of chronic illnesses. Vascular access procedures, which
include the insertion of devices such as central venous catheters, peripherally
inserted central catheters (PICCs), and arteriovenous fistulas, are critical
for administering medications, nutrition, dialysis, and for blood sampling. A
rise in hospital admissions for chronic conditions like cancer, kidney disease,
and cardiovascular ailments has led to a corresponding surge in the need for
efficient and long-term vascular access solutions. The aging global population,
which is more prone to comorbidities requiring regular medical interventions,
is also contributing to higher procedure volumes. Rising surgical volumes,
longer hospital stays, and increasing preferences for home-based care with
portable infusion devices are accelerating the market demand for safe,
reliable, and easy-to-insert vascular access devices.
The market is also shaped by notable technological
innovations and trends. Advancements in catheter materials and designs, such as
antimicrobial coatings and ultrasound-guided insertion techniques, are reducing
complications such as infections and thrombosis. The integration of imaging and
navigation technologies into vascular access procedures is making device
placement more accurate and reducing the rate of failed insertions. A shift
toward minimally invasive access techniques is gaining traction, particularly
in outpatient and ambulatory settings, leading to improved patient comfort and
reduced healthcare costs. Market participants are focusing on launching
user-friendly and cost-effective devices that cater to both high-volume
hospitals and low-resource settings. Increasing training and awareness among
healthcare providers regarding device selection and insertion protocols is
further improving procedural success rates and patient safety.
Despite the positive momentum, several challenges
persist in the Global Vascular Access Procedures Market. High costs associated
with advanced vascular access devices and procedures can limit their adoption
in lower-income or resource-constrained settings. Device-related complications
such as catheter-related bloodstream infections (CRBSIs), occlusions, and
mechanical failures continue to pose significant clinical risks. Variability in
clinician skill levels and lack of standardized insertion techniques across
facilities often result in inconsistent patient outcomes. Stringent regulatory
requirements for the approval of new vascular access devices may delay product
launches and hinder innovation. Moreover, concerns over device durability,
frequent replacements, and patient discomfort may discourage adoption in some
patient populations. Addressing these challenges through improved training,
patient-specific device design, and ongoing clinical studies will be crucial in
ensuring sustainable market growth.
Key Market Drivers
Growing
Prevalence of Chronic Diseases Requiring Long-term Vascular Access
The growing prevalence of chronic diseases that
require long-term vascular access is one of the most significant drivers of the
Global Vascular Access Procedures Market. Chronic kidney disease (CKD)
alone affects more than 800 million people globally, accounting for over 10% of
the world’s population, and its prevalence continues to increase, especially in
low- and middle-income countries due to rising rates of diabetes and
hypertension. A large proportion of CKD patients depend on
hemodialysis, which demands reliable vascular access methods such as
arteriovenous fistulas, grafts, and central venous catheters. These access
points are critical for ensuring efficient dialysis sessions and improving
patient survival outcomes.
Cancer incidence is another major factor contributing
to market growth. In 2022, there were nearly 20 million new cancer cases
and about 9.7 million deaths worldwide. Many cancer patients undergo
chemotherapy, targeted therapy, and supportive treatments requiring long-term
intravenous access through devices like implantable ports or peripherally
inserted central catheters (PICCs). In parallel, the burden of severe
infections and sepsis remains extremely high, with 48.9 million cases and 11
million related deaths annually, representing one in every five deaths
globally. These cases frequently necessitate prolonged antibiotic
administration via secure vascular access devices.
Technological advancements have further strengthened
the role of vascular access procedures in chronic disease management. The
introduction of antimicrobial-coated catheters, ultrasound-guided insertion
techniques, and needle-free connectors has improved safety, reduced infection
risks, and extended device longevity. Growing awareness among healthcare
providers about early vascular access planning, especially for patients with
progressive chronic illnesses, is improving treatment efficiency and patient quality
of life. With aging populations and rising comorbidity rates, demand for
dependable, long-term vascular access solutions is expected to accelerate,
driving substantial market expansion in the years ahead.
Increasing
Surgical Procedures and Emergency Care Volume
The increasing volume of surgical procedures and
emergency care cases is a crucial growth driver for the Global Vascular Access
Procedures Market. According to the Lancet, approximately 234 million
major surgical operations are performed globally each year, highlighting the
magnitude of procedural demand. These surgeries from elective
operations to life-saving interventions often require rapid and reliable
vascular access for administering anesthesia, administering fluids, delivering
medications, and conducting diagnostic testing.
Emergency departments also play a significant role in
market expansion. Data from the OECD shows that ED visit rates averaged
27 visits per 100 people annually across 25 OECD countries in 2021.
High volumes of emergency admissions for trauma, acute infections like sepsis,
and cardiovascular events drive increased use of vascular access devices such
as central venous catheters and peripheral lines in critical care settings.
This dual surge in surgical and emergency care demand
stems largely from demographic shifts, aging populations face higher rates of
chronic diseases like cancer, diabetes, and kidney disorders, which frequently
require both planned and urgent medical interventions. Hospitals and surgical
centers are investing in training and deploying advanced vascular access
technologies to reduce procedural delays, minimize complications such as
infections, and improve patient safety.
Growing global healthcare infrastructure, including
expansions in outpatient surgical facilities and enhanced emergency care
capabilities, continues to support the upward trajectory in vascular access
procedures. This sustained rise in surgical and emergency care volumes is
fueling the demand for efficient, safe, and high-quality vascular access
solutions, presenting compelling opportunities for manufacturers and healthcare
providers.
Advancements
in Device Technology and Materials
Advancements in device technology and
materials are playing a pivotal role in driving growth in the Global Vascular
Access Procedures Market by improving the safety, efficacy, and longevity of
vascular access devices. Continuous innovations have led to the development of
catheters, ports, and fistula devices with enhanced biocompatibility,
antimicrobial coatings, and designs that reduce the risk of complications such
as thrombosis, infection, and device failure. Modern vascular access devices
are being engineered with advanced materials like polyurethane and silicone
blends, which offer improved flexibility, durability, and patient comfort,
allowing for longer indwelling times without compromising performance. The
integration of antimicrobial and heparin-bonded coatings helps prevent biofilm
formation and clotting, which are critical issues in long-term vascular access.
Technological progress has also brought forth devices with improved tip
designs, facilitating smoother insertion and reducing vessel trauma, which not
only minimizes patient discomfort but also supports faster recovery.
The adoption of imaging-guided insertion
techniques, supported by high-resolution ultrasound and fluoroscopy, has
enhanced placement accuracy, reducing procedural risks and improving outcomes.
Manufacturers are also focusing on developing patient-specific and customizable
devices to meet the needs of complex cases, such as pediatric or oncology
patients, where standard devices may not be suitable. These innovations are
expanding the applicability of vascular access in multiple therapeutic areas,
including hemodialysis, chemotherapy, parenteral nutrition, and long-term
antibiotic administration. As healthcare providers seek to improve procedural
efficiency, patient safety, and cost-effectiveness, the availability of
technologically advanced devices made from high-performance materials is
accelerating adoption rates across hospitals, specialty clinics, and outpatient
centers, positioning technological innovation as a key growth driver for the
market.
Download Free Sample Report
Key Market Challenges
High
Risk of Complications Associated with Vascular Access Devices
The Global Vascular Access Procedures
Market faces a significant challenge due to the high risk of complications
associated with vascular access devices, which can impact patient outcomes and
limit procedural adoption. Complications such as catheter-related bloodstream
infections (CRBSIs), thrombosis, stenosis, hematoma formation, and device
malfunction are common concerns that can arise during or after the procedure.
Infections remain one of the most critical risks, as they not only lead to
increased morbidity but also escalate healthcare costs due to prolonged
hospital stays, additional treatments, and the need for device replacement.
Thrombosis and stenosis can compromise the efficiency of vascular access,
requiring repeat interventions that increase the burden on both healthcare
systems and patients. In certain cases, repeated procedures can lead to limited
viable access sites, especially in patients undergoing long-term treatments
like hemodialysis or chemotherapy.
The risk of complications is amplified
in patients with multiple comorbidities, weakened immune systems, or poor
vascular health, making device placement and maintenance more challenging. A
lack of standardized training protocols for device insertion and maintenance in
some regions contributes to procedural variability, which can further elevate
complication rates. Concerns about these risks often lead to hesitancy among
healthcare providers and patients, slowing adoption of advanced vascular access
solutions despite their potential benefits. This challenge necessitates
continuous innovation in device design, incorporation of antimicrobial
coatings, and the implementation of strict infection control protocols. Without
addressing these safety concerns effectively, market growth may be hindered due
to the potential for adverse events that undermine trust in vascular access
procedures.
Shortage
of Skilled Healthcare Professionals
The shortage of skilled healthcare
professionals is a significant challenge impacting the Global Vascular Access
Procedures Market, as these procedures require a high level of technical
expertise, precision, and clinical judgment to ensure patient safety and
optimal outcomes. In many regions, particularly in low- and middle-income
countries, there is a lack of adequately trained vascular surgeons,
interventional radiologists, and specialized nursing staff capable of
performing and managing vascular access procedures effectively. Even in
developed healthcare systems, the growing patient demand for dialysis,
chemotherapy, parenteral nutrition, and other treatments requiring reliable
vascular access is outpacing the availability of qualified professionals. This
shortage often results in procedural delays, suboptimal device placement, and
an increased risk of complications such as infection, thrombosis, and device
failure.
Training programs for vascular access
procedures can be resource-intensive, requiring access to simulation-based
learning, mentorship, and clinical exposure, which limits the speed at which
new professionals can be developed. High staff turnover, burnout, and migration
of skilled professionals to countries offering better pay and working
conditions further intensify this gap. In rural and underserved areas, the lack
of trained personnel forces patients to travel long distances for specialized
care, which can delay treatment initiation and negatively affect health
outcomes. The situation is compounded by the rapid evolution of vascular access
technologies, which demands continuous upskilling and retraining of healthcare
providers. Without a robust strategy to address the skills gap through targeted
training initiatives, retention programs, and incentivized career pathways, the
shortage of skilled healthcare professionals will remain a critical bottleneck
for market growth in the coming years, impacting both procedural capacity and
patient care quality.
Key Market Trends
Rising
Adoption of Image-Guided Vascular Access Techniques
The Global Vascular Access Procedures
Market is witnessing a notable trend with the rising adoption of image-guided
vascular access techniques, driven by the growing demand for precision, safety,
and efficiency in medical interventions. Image-guided procedures, using
ultrasound, fluoroscopy, or other imaging modalities, allow clinicians to
visualize the vascular anatomy in real time, significantly reducing the risk of
complications such as arterial puncture, hematoma, or catheter misplacement.
This approach is particularly valuable in complex patient cases, including
those with challenging vascular anatomy, pediatric patients, and individuals
requiring repeated access for treatments like dialysis or chemotherapy. The
integration of imaging technologies into vascular access workflows is improving
first-attempt success rates, minimizing patient discomfort, and reducing
procedure time, which enhances both clinical outcomes and operational
efficiency in healthcare settings.
Technological advancements in portable
and handheld ultrasound devices are expanding the accessibility of image-guided
procedures beyond specialized centers to community hospitals and outpatient
clinics. This trend is also supported by growing clinical evidence
demonstrating superior safety profiles and long-term patency rates when image
guidance is employed. Training initiatives and skill development programs by
medical societies and device manufacturers are equipping healthcare
professionals with the expertise to adopt these techniques more widely. As
healthcare systems prioritize patient safety, cost-effectiveness, and adherence
to evidence-based practices, the shift toward image-guided vascular access is
becoming a standard of care across multiple therapeutic areas, positioning it
as a critical driver of procedural evolution in the market.
Integration
of Antimicrobial and Antithrombogenic Coatings in Catheters
The integration of antimicrobial and
antithrombogenic coatings in catheters is emerging as a transformative trend in
the Global Vascular Access Procedures Market, aimed at enhancing patient safety
and device performance. These specialized coatings are designed to address two
of the most common and critical complications associated with vascular
access—catheter-related bloodstream infections (CRBSIs) and thrombosis.
Antimicrobial coatings work by inhibiting the growth of pathogenic
microorganisms on the catheter surface, significantly reducing infection risks
during prolonged use, which is especially vital for patients undergoing
treatments such as hemodialysis, chemotherapy, and long-term intravenous
therapies. Antithrombogenic coatings, on the other hand, help prevent blood
clot formation by minimizing platelet adhesion and fibrin deposition on the
catheter, ensuring uninterrupted blood flow and extending the functional life
of the device.
The increasing adoption of these
advanced coatings is driven by the need to improve clinical outcomes, lower
hospitalization rates, and reduce the economic burden associated with treating
catheter-related complications. Regulatory bodies and healthcare institutions
are placing greater emphasis on infection control standards, prompting
manufacturers to innovate and incorporate such coatings into next-generation
vascular access devices. Continuous R&D efforts are leading to the
development of multifunctional coatings that combine antimicrobial and
antithrombogenic properties, offering comprehensive protection without
compromising catheter flexibility or biocompatibility. With growing clinical
evidence supporting their efficacy, these coatings are expected to witness
accelerated uptake across both developed and emerging healthcare markets. This
trend aligns with the broader shift toward patient-centric solutions that
prioritize safety, efficiency, and long-term treatment success.
Segmental Insights
Procedure
Insights
Based
on the Procedure, Arteriovenous Fistulas emerged as the dominant segment in
the Global Vascular Access Procedures Market in 2024. This is due to their
critical role in long-term hemodialysis treatment for patients suffering from
end-stage renal disease (ESRD). AV fistulas are widely recognized as the most
preferred vascular access method because they provide superior durability,
reduced infection rates, and better blood flow compared to other access types
such as catheters or grafts. This has made them the gold standard in dialysis
access, particularly in healthcare systems with advanced nephrology services.
With the rising global burden of chronic kidney disease (CKD), especially in
aging populations, the number of dialysis patients has surged, driving demand
for reliable and long-lasting vascular access procedures like AV fistulas. Another
key factor supporting the dominance of AV fistulas is the growing awareness
among healthcare providers and patients regarding the long-term benefits of
this procedure, including lower hospitalization rates and reduced
complications. Technological improvements in surgical techniques and
preoperative vascular imaging have further improved the success and maturation
rates of AV fistulas.
Application
Insights
Based on the Application, Hemodialysis emerged as the
dominant segment in the
Global Vascular Access Procedures Market in 2024. This dominance is due to the
increasing global prevalence of chronic kidney disease (CKD) and end-stage
renal disease (ESRD), which necessitate routine and long-term dialysis
treatments. Hemodialysis remains the most commonly adopted renal replacement
therapy, requiring reliable vascular access for the efficient removal and
return of blood during treatment. This growing dependency on hemodialysis has
significantly propelled the demand for vascular access procedures such as
arteriovenous fistulas, grafts, and central venous catheters, particularly in
aging populations and regions with high incidences of diabetes and hypertension
which is a key risk factors for kidney disease. The segment's dominance is also
reinforced by healthcare systems prioritizing early diagnosis and proactive CKD
management. Advancements in vascular access techniques, improved imaging for
vessel selection, and better patient monitoring have enhanced the success and
sustainability of hemodialysis access.
Download Free Sample Report
Regional Insights
North America emerged
as the dominant region in the Global Vascular Access Procedures Market in 2024. This is primarily due to its advanced
healthcare infrastructure, high prevalence of chronic diseases, and strong
presence of leading medical device manufacturers. The United States, in
particular, has witnessed a substantial burden of chronic kidney disease (CKD),
diabetes, and cardiovascular disorders, conditions that frequently require
vascular access procedures for long-term treatment such as hemodialysis,
chemotherapy, and intravenous therapy. The availability of skilled healthcare
professionals and early adoption of cutting-edge technologies such as
image-guided catheter placement and bioengineered grafts has further
strengthened the region’s leadership in this market. Favorable reimbursement
policies and significant government investments in healthcare services have
encouraged the expansion of vascular access centers and outpatient dialysis
clinics.
Recent Developments
- In April 2025, Peak Mobile Holdings, a
leading U.S. provider of mobile healthcare services, acquired New England
Vascular Access, a top mobile vascular access provider in New Hampshire,
Vermont, and Maine. The move strengthens Peak’s Northeast presence and expands
its ability to deliver hospital-grade vascular access services in skilled
nursing facilities, infusion centers, and patient homes, supporting timely care
and reducing pressure on inpatient systems.
- In October 2024, Becton, Dickinson and Company (BD) introduced
the BD Intraosseous Vascular Access System, a significant advancement in
emergency medicine. This innovative device provides rapid and reliable access
to the patient’s circulatory system when conventional intravenous (IV) methods
prove challenging or unfeasible. By facilitating needle insertion directly into
the bone marrow cavity, the system enables swift delivery of fluids and
life-saving medications during critical situations, minimizing delays in
patient care.
- In May 2024, Teleflex Incorporated, a pioneer in
intraosseous vascular access solutions, launched the Arrow EZ-IO Intraosseous
Access Procedure Tray. Designed as a single-use, sterile kit, it contains all
necessary instruments for performing IO access, enabling clinicians to execute
the procedure with greater speed, precision, and convenience. The streamlined
format aims to standardize emergency interventions, reduce procedural
variability, and optimize readiness in critical care environments such as trauma
centers and field hospitals.
- In October 2023, B. Braun Medical Inc., a recognized
leader in infusion therapy, unveiled the Introcan Safety 2 IV Catheter with
Multi-Access Blood Control, reinforcing its commitment to patient and
healthcare worker safety. The device incorporates a fully passive needlestick
protection mechanism to mitigate accidental injuries, while its integrated
blood control system minimizes exposure to blood with every hub access,
substantially lowering the risk of bloodborne pathogen transmission. By
integrating safety features with enhanced functionality, B. Braun continues to
strengthen infection control measures and occupational safety standards in
vascular access procedures.
Key Market Players
- Teleflex
Incorporated
- Becton,
Dickinson and Company
- B.
Braun Melsungen AG
- ICU
Medical, Inc.
- Cook
Group Incorporated
- AngioDynamics,
Inc.
- Medtronic
plc
- Medical
Components, Inc.
- Terumo
Corporation
- Access
Vascular, Inc.
|
By Procedure
|
By Application
|
By Region
|
- Arteriovenous Fistulas
- Arteriovenous Grafts
- Central Venous Catheters
- Others
|
- Chemotherapy
- Hemodialysis
- Blood Transfusions
- Intravenous Antibiotics Treatment
- Others
|
- North America
- Europe
- Asia Pacific
- South America
- Middle East & Africa
|
Report Scope:
In this report, the Global Vascular
Access Procedures Market has been segmented into the following categories, in
addition to the industry trends which have also been detailed below:
- Vascular
Access Procedures Market, By Procedure:
o
Arteriovenous
Fistulas
o
Arteriovenous
Grafts
o
Central
Venous Catheters
o
Others
- Vascular
Access Procedures Market, By Application:
o
Chemotherapy
o
Hemodialysis
o
Blood
Transfusions
o
Intravenous
Antibiotics Treatment
o
Others
- Vascular
Access Procedures Market, By Region:
o
North
America
§
United
States
§
Canada
§
Mexico
o
Europe
§
France
§
United
Kingdom
§
Italy
§
Germany
§
Spain
o
Asia-Pacific
§
China
§
India
§
Japan
§
Australia
§
South
Korea
o
South
America
§
Brazil
§
Argentina
§
Colombia
o
Middle
East & Africa
§
South
Africa
§
Saudi
Arabia
§
UAE
Competitive Landscape
Company
Profiles: Detailed
analysis of the major companies present in the Global Vascular Access
Procedures Market.
Available Customizations:
Global Vascular Access Procedures Market report with the given market data,
TechSci Research offers customizations according to a company's specific needs.
The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to
five).
Global Vascular Access Procedures Market is an upcoming report to be released
soon. If you wish an early delivery of this report or want to confirm the date
of release, please contact us at [email protected]